This is the authors' abstract. We don't add key points for this paper.
Lung cancer still remains the leading cause of cancer-related mortality worldwide. Among the emerging biomarkers predictive for target therapy, Erythroblastic oncogene B (ERBB2) is recommended by the main international guidelines to be investigate, according to several novel therapeutic approaches. Aim of this retrospective study was to analyze the distribution of ERBB2 mutations and their … Continued
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Bessi et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: